肝細胞癌合并門靜脈癌栓聯合肝靜脈栓塞介入轉化縮小病肝體積后行吲哚菁綠輔助腹腔鏡右半肝切除1例報告_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

高偉 ¹ , 吳昊鈞 ² , 魏波 ³ ,  陳利平 ²

1. ;
2. ;
3. ;

Corresponding?author：

陳利平, Email: schxclp@sina.com

Keywords：

門靜脈癌栓; 肝靜脈栓塞; 轉化治療; 吲哚菁綠; 腹腔鏡右半肝切除

DOI：

10.7507/1007-9424.202207018

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 高偉, 吳昊鈞, 魏波, 陳利平. 肝細胞癌合并門靜脈癌栓聯合肝靜脈栓塞介入轉化縮小病肝體積后行吲哚菁綠輔助腹腔鏡右半肝切除1例報告. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2023, 30(2): 221-223. doi: 10.7507/1007-9424.202207018 Copy

1.	Bruix J, Cheng AL, Meinhardt G, et al. Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: analysis of two phase Ⅲ studies. J Hepatol, 2017, 67(5): 999-1008.
2.	Chao Y, Chung YH, Han G, et al. The combination of transcatheter arterial chemoembolization and sorafenib is well tolerated and effective in Asian patients with hepatocellular carcinoma: final results of the START trial. Int J Cancer, 2015, 136(6): 1458-1467.
3.	中國醫師協會肝癌專業委員會. 肝細胞癌合并門靜脈癌栓多學科診治中國專家共識(2018年版). 臨床肝膽病雜志, 2019, 35(4): 737-743.
4.	程樹群, 吳孟超, 陳漢, 等. 肝癌門靜脈癌栓分型的影像學意義. 中華普通外科雜志, 2004, 19(4): 200-201.
5.	Cheng SQ, Wu MC, Chen H, et al. Tumor thrombus types influence the prognosis of hepatocellular carcinoma with the tumor thrombi in the portal vein. Hepatogastroenterology, 2007, 54(74): 499-502.
6.	Chebaro A, Buc E, Durin T, et al. Liver venous deprivation or associating liver partition and portal vein ligation for staged hepatectomy?: a retrospective multicentric study. Ann Surg, 2021, 274(5): 874-880.
7.	劉杰, 張成武, 洪德飛, 等. 腹腔鏡前入路右半肝切除術治療右肝巨大腫瘤. 中華普通外科雜志, 2017, 32(7): 581-584.
8.	關斌穎, 楊國際, 劉天錫. 吲哚菁綠熒光染色技術在腹腔鏡精準肝切除術中的應用體會. 腹腔鏡外科雜志, 2020, 25(12): 919-924.

1. Bruix J, Cheng AL, Meinhardt G, et al. Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: analysis of two phase Ⅲ studies. J Hepatol, 2017, 67(5): 999-1008.
2. Chao Y, Chung YH, Han G, et al. The combination of transcatheter arterial chemoembolization and sorafenib is well tolerated and effective in Asian patients with hepatocellular carcinoma: final results of the START trial. Int J Cancer, 2015, 136(6): 1458-1467.
3. 中國醫師協會肝癌專業委員會. 肝細胞癌合并門靜脈癌栓多學科診治中國專家共識(2018年版). 臨床肝膽病雜志, 2019, 35(4): 737-743.
4. 程樹群, 吳孟超, 陳漢, 等. 肝癌門靜脈癌栓分型的影像學意義. 中華普通外科雜志, 2004, 19(4): 200-201.
5. Cheng SQ, Wu MC, Chen H, et al. Tumor thrombus types influence the prognosis of hepatocellular carcinoma with the tumor thrombi in the portal vein. Hepatogastroenterology, 2007, 54(74): 499-502.
6. Chebaro A, Buc E, Durin T, et al. Liver venous deprivation or associating liver partition and portal vein ligation for staged hepatectomy?: a retrospective multicentric study. Ann Surg, 2021, 274(5): 874-880.
7. 劉杰, 張成武, 洪德飛, 等. 腹腔鏡前入路右半肝切除術治療右肝巨大腫瘤. 中華普通外科雜志, 2017, 32(7): 581-584.
8. 關斌穎, 楊國際, 劉天錫. 吲哚菁綠熒光染色技術在腹腔鏡精準肝切除術中的應用體會. 腹腔鏡外科雜志, 2020, 25(12): 919-924.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

肝細胞癌合并門靜脈癌栓聯合肝靜脈栓塞介入轉化縮小病肝體積后行吲哚菁綠輔助腹腔鏡右半肝切除1例報告

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content